No vaccine has yet been developed to prevent the new corona virus, and work is under way around the world. But there is growing evidence that the current vaccines may be helpful in treating coronavirus-related disease 19, even though they are not ready for it.
Clinical trials are being conducted on the BCG vaccine used to prevent TB in various countries around the world, as experts believe that it may be effective in preventing Code 19.
Scientists believe the BCG vaccine can strengthen people’s immune responses, reduce the effects of the new corona virus and reduce the risk of symptoms or problems associated with code 19.
A study published in the medical journal M Bio suggests that the MMR (measles, mumps, rubella or German measles) vaccine may have the same effects as the TB vaccine.
The vaccine is commonly used in children around the world, and research suggests that it may reduce the risk of severe edema and death in patients with COD 19, while clinical trials in medical staff have suggested. ۔
Such vaccines contain real viruses or bacteria that scientists weaken in the laboratory.
Research reports have shown that such vaccines also protect against other diseases by ‘training’ the immune system.
These vaccines help in the unconventional immune response and are the first defense against the disease.
Dr. Paul Fidel Jr., associate dean of the Louisiana State University School of Dentistry, who was involved in the new study, said such vaccines not only increase immunity against certain germs but also provide unconventional benefits.
Dr. Paul Fidel worked with Dr. Marie Nower, a professor of microbiology and immunology at Tolan University of Medicine, and the results showed that these vaccines protect a type of immune cell through MDSC.
Medical experts have shown in experiments on mice that these cells reduce the risk of inflammation and death from any disease, while the new study also found that such vaccines also infect infections with MDSC. Possible protection can be found.
The researchers said that an MMR vaccine could help fight lung inflammation and infection by involving MDSC cells in people infected with code 19, a common problem in severe cases of the disease.
As proof of this, he presented 955 USS Roosevelt sailors as a test case in which Code 19 was confirmed but its severity was mild.
The researchers said that this is probably because all people in the US Navy undergo MMR vaccination, but their age and physical fitness also play a role in maintaining good health.
Other evidence supports a link between the MMR vaccine and Code 19. The data revealed that people living in areas where the MMR vaccine is common have a lower mortality rate than Code 19. Gone
Code 19 is also a potentially less contagious disease for children and is also caused by vaccinations, meaning that vaccines such as TB or MMR are playing a potential role in protecting children.
The study found that adults who received the MMR vaccine in Bachchan may have antibodies to protect against measles and other diseases, but the presence of MDSC cells is unlikely.
The researchers said that this meant that they needed a booster vaccine to provide some protection against code 19.
“Although MDSCs are long-lived cells that do not last a lifetime, a booster MMR can give them new life. We expect that these cells will last a lifetime in people undergoing re-vaccination,” he said. Will be present and they will be able to go through the difficult time of this epidemic.
The researchers suggested a clinical trial of the MMR vaccine in the medical staff, while they were also funded to compare MMR and BCG vaccines with Code 19.
The researchers said that if their idea proved correct, the MMR vaccine could help save lives during the Code 19 epidemic